CYLD is a de-ubiquitinating enzyme that plays a key role in immunity by negatively regulating NF-kB transcription factor and JNK kinase signaling. In this project we aim to evaluate the physiological function of CYLD cleavage upon T cell receptor stimulation in mice and patients with inflammatory and autoimmune disorders.